Reference Hub1
Improving Clinical Trial Diversity: The Impending Role of Technology-Oriented Strategies Amid the COVID-19 Pandemic

Improving Clinical Trial Diversity: The Impending Role of Technology-Oriented Strategies Amid the COVID-19 Pandemic

Rebecca R. Johnson, Michelle Lee D'Abundo
ISBN13: 9781799884903|ISBN10: 1799884902|EISBN13: 9781799884910
DOI: 10.4018/978-1-7998-8490-3.ch017
Cite Chapter Cite Chapter

MLA

Johnson, Rebecca R., and Michelle Lee D'Abundo. "Improving Clinical Trial Diversity: The Impending Role of Technology-Oriented Strategies Amid the COVID-19 Pandemic." Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity, edited by Nick Comninellis and Steven D. Waldman, IGI Global, 2022, pp. 348-377. https://doi.org/10.4018/978-1-7998-8490-3.ch017

APA

Johnson, R. R. & D'Abundo, M. L. (2022). Improving Clinical Trial Diversity: The Impending Role of Technology-Oriented Strategies Amid the COVID-19 Pandemic. In N. Comninellis & S. Waldman (Eds.), Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity (pp. 348-377). IGI Global. https://doi.org/10.4018/978-1-7998-8490-3.ch017

Chicago

Johnson, Rebecca R., and Michelle Lee D'Abundo. "Improving Clinical Trial Diversity: The Impending Role of Technology-Oriented Strategies Amid the COVID-19 Pandemic." In Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity, edited by Nick Comninellis and Steven D. Waldman, 348-377. Hershey, PA: IGI Global, 2022. https://doi.org/10.4018/978-1-7998-8490-3.ch017

Export Reference

Mendeley
Favorite

Abstract

Racially and ethnically diverse populations are underrepresented as participants in clinical trials. The disproportionate impact COVID-19 has on communities of color intensifies the imperativeness of equitable access. The purpose of this chapter is to explore how clinical research stakeholders can adapt their traditional approaches to recruitment, research conduct, and design sparked by the current healthcare crisis through technology-oriented strategies designed to increase diverse representation in clinical trials. Strategies utilizing technology will be recommended by examining this issue from a centralized and local perspective across a patient's journey in a clinical trial, with a specific focus on fostering long-term, trusting community relationships. Technology-oriented strategies including health information technology and digital media may provide promising solutions for improving clinical trial diversity amid a transitioning environment that is already adapting to virtual methods for communicating and engaging with patients regarding clinical research.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.